2240 Anbarasu et al.
Asian J. Chem.
TABLE-2
INHIBITION ZONE FOR PYRAZINIUM CHLOROCHROMATE
Control 100 µL added and zone of inhibition (mm/mL)
Organisms
Gram stain
25 µL
10
12
12
14
–
14
10
12
10
12
10
–
75 µL
12
14
15
17
10
16
12
14
11
15
11
10
12
50 µL
14
16
18
21
11
18
14
16
13
18
12
11
14
100 µL
16
18
20
25
12
20
16
18
15
21
14
12
Control
28
22
22
15
20
20
25
25
23
30
12
12
Streptococcus
Bacillus cereus
Entrococcus
Proteus vulgaris
Micrococcus
Mycobacterium tuberclosis Gram-positive bacteria
Azotobacter
E. coli
Pseudomonas aeruginosa
Candida albicans
A. niger
Fusarium
Trichoderma
Gram-positive bacteria
Gram-positive bacteria
Gram-positive bacteria
Gram-negative bacteria
Gram-positive bacteria
Gram-negative bacteria
Gram-negative bacteria
Gram-negative bacteria
Fungi
Fungi
Fungi
Fungi
10
16
14
17. R.S. Kumar, I.A. Arif, A. Ahamed and A. Idhayadhulla, Saudi J. Biol.
Sci., 23, 614 (2016);
cereus, Proteus vulgaris, Mycobacterium tuberclosis, Aspergiullus
niger, Fusarium, Trichoderma and pyrazinium chlorochromate
were resistant towardsEntrococcus, Proteus vulgaris, Mycobac-
terium tuberclosis, Aspergiullus niger andFusarium,Trichoderma.
18. P.P. Lovisolo, G. Briatico-Vangosa, G. Orsini, R. Ronchi, R. Angelucci
and G. Valzelli, Pharmacol. Res. Commun., 13, 151 (1981);
19. C.P. Meher, A.M. Rao and Md. Omar, Asian J. Pharm. Sci. Res., 3, 43
(2013).
CONFLICT OF INTEREST
20. M. Shahar Yar, A.A. Siddiqui and M.A. Ali, Bioorg. Med. Chem. Lett.,
16, 4571 (2006);
The authors declare that there is no conflict of interests
regarding the publication of this article.
21. M. Shahar Yar, M.A. Bakht, A.A. Siddiqui, M.M. Abdullah and E. De
Clercq, J. Enzym. Inhib. Med. Chem., 24, 876 (2009);
22. M.A. Ali, M.S. Yar, M. Kumar and G.S. Pandian, Nat. Prod. Res., 21,
575 (2007);
REFERENCES
1. A.P. Taylor, R.P. Robinson, Y.M. Fobian, D.C. Blakemore, L.H. Jones
and O. Fadeyi, Org. Biomol. Chem., 14, 6611 (2016);
https://doi.org/10.1039/C6OB00936K.
2. R. Chawla, U. Sahoo, A. Arora, P.C. Sharma and V. Radhakrishnan,
Acta Pol. Pharm. Drug Res., 67, 55 (2010).
3. A.R. Katritzky, Chem. Rev., 104, 2125 (2004);
4. M.E.Azab, M.M.Youssef and E.A. El-Bordany, Molecules, 18, 832 (2013);
23. S.N. Mokale, M.C. Nevase, N.S. Sakle, P.N. Dube, V.R. Shelke, S.A.
Bhavale and A. Begum, Bioorg. Med. Chem. Lett., 24, 2155 (2014);
24. G. Turan-Zitouni, L.Yurttas, Z.A. Kaplancikli, Ö.D. Can and Ü. Demir
Özkay, Med. Chem. Res., 24, 2406 (2015);
25. A. Iqbal, H. Siddiqui, C. Ashraf, M. Ahmad and G. Weaver, Molecules,
12, 245 (2007);
5. K.G. Sekar and G. Manikandan, Oxid. Commun., 35, 577 (2012).
6. B.H. Asghar, Arab. J. Chem.;
26. M. Urban, J. Sarek, M. Kvasnica, I. Tislerova and M. Hajduch, J. Nat. Prod.,
70, 526 (2007);
7. H. Foks, D. Pancechowska-Ksepko,A. Kedzia, Z. Zwolska, M. Janowiec
and E. Augustynowicz-Kopec, II Farmaco, 60, 513 (2005);
8. E. Abignente, Actual Chim. Ther., 18, 193 (1991).
9. P. Gund and T.Y. Shen, J. Med. Chem., 20, 1146 (1977);
10. E.Abignente, P. de Caprariis, M.G. Rimoli, L.Avallone, L. Gomez Paloma,
F. Rossi, M. D’Amico, V. Calderaro and C. Parrillo, Eur. J. Med. Chem.,
28, 337 (1993);
27. M. Kucerova-Chlupacova, M. Dosedel, J. Kunes, M. Soltesova-Prnova,
M. Majekova and M. Stefek, Monatsh. Chem., 149, 921 (2018);
28. X. Wang, T. Zhao, B. Yang, Z. Li, J. Cui, Y. Dai, Q. Qiu, H. Qiang, W.
Huang and H. Qian, Bioorg. Med. Chem. Lett., 23, 132 (2015);
29. A. GhafoorandS.A.J. Khan, ListofDiseasesofEcononomicPlantsinPakistan,
Ministry of Food and Agriculture, Islamabad, Pakistan, pp. 26 (1976).
30. I. Rzewnicki, E. Olszewska and D. Rogowska-Szadkowska, Med. Sci.
Monit., 18, RA17 (2012);
31. G.L. Gard, H.B. Davis, R.M. Sheets, J.M. Brannfors and W.W. Paudler,
Heterocycles, 20, 2029 (1983);
32. C.F. Koelsch, J. Am. Chem. Soc., 53, 304 (1931);
33. Atta-ur-Rahman, M.I. Choudhary and W.J. Thomsen, Bioassay Techni-
ques for Drug Dtwelopment, Harwood Academic Publishers, The
Netherlands, p. 16 (2001).
34. K.M. Khan, Z.S. Saify, M.Z. Khan, Zia-Ullah, M.I. Choudhary, Atta-
ur-Rahman, S. Perveen, Z.H. Chohan and C.T. Supuran, J. Enzym. Inhib.
Med. Chem., 19, 373 (2004);
Krishnakumar, World J. Pharm. Pharm. Sci., 3, 1124 (2014).
12. M. Gür, N. Sener, H. Muglu, M.S. Çavus, O.E. Özkan, F. Kandemirli
and I. Sener, J. Mol. Struct., 1139, 111 (2017);
13. K. Nishie, A.C. Waiss Jr. and A.C. Keyl, Toxicol. Appl. Pharmacol., 17,
244 (1970);
14. L. Racané, S. Kraljevic Pavelic, I. Ratkaj, V. Stepanic, K. Pavelic, V. Tralic-
Kulenovic and G. Karminski-Zamola, Eur. J. Med. Chem., 55, 108 (2012);
15. B.V. Clineschmidt, J.C. McGuffin andA.B. Pflueger, Eur. J. Pharmacol.,
44, 65 (1977);
16. N. Dias, U. Jacquemard, B. Baldeyrou, A. Lansiaux, J.-F. Goossens, C.
Bailly, S. Routier and J.-Y. Mérour, Eur. J. Med. Chem., 40, 1206 (2005);